Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Erika Comasco |
Documentos disponibles escritos por este autor (2)
Refinar búsqueda
Sleep duration, depression, and oxytocinergic genotype influence prepulse inhibition of the startle reflex in postpartum women / Erika Comasco en European Neuropsychopharmacology, Año 2016 - Vol. 26 - No. 4 (Abril)
[artículo]
Título : Sleep duration, depression, and oxytocinergic genotype influence prepulse inhibition of the startle reflex in postpartum women Tipo de documento: texto impreso Autores: Erika Comasco, Autor ; Maria E. Gulinello, Autor ; Charlotte Hellgren, Autor Fecha de publicación: 2021 Artículo en la página: pp. 767-776 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: COMT, Genotipo, Oxitocina, Depresión post-parto, Inhibición prepulso, Dormir Resumen: The postpartum period is characterized by a post-withdrawal hormonal status, sleep deprivation, and susceptibility to affective disorders. Postpartum mothering involves automatic and attentional processes to screen out new external as well as internal stimuli. Link: ./index.php?lvl=notice_display&id=26575
in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 4 (Abril) . - pp. 767-776[artículo] Sleep duration, depression, and oxytocinergic genotype influence prepulse inhibition of the startle reflex in postpartum women [texto impreso] / Erika Comasco, Autor ; Maria E. Gulinello, Autor ; Charlotte Hellgren, Autor . - 2021 . - pp. 767-776.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 4 (Abril) . - pp. 767-776
Palabras clave: COMT, Genotipo, Oxitocina, Depresión post-parto, Inhibición prepulso, Dormir Resumen: The postpartum period is characterized by a post-withdrawal hormonal status, sleep deprivation, and susceptibility to affective disorders. Postpartum mothering involves automatic and attentional processes to screen out new external as well as internal stimuli. Link: ./index.php?lvl=notice_display&id=26575 Ulipristal acetate for treatment of premenstrual dysphoric disorder / Erika Comasco en The American Journal of Psychiatry, Año 2021 - Vol. 178 - No.3 (Marzo)
[artículo]
Título : Ulipristal acetate for treatment of premenstrual dysphoric disorder : a proof-of-concept randomized controlled trial Tipo de documento: texto impreso Autores: Erika Comasco, Autor ; Helena Kopp Kallner, Autor ; Marie Bixo, Autor Fecha de publicación: 2021 Artículo en la página: pp. 256-265 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno disfórico premenstrual, Neuroendocrinología, Acetato de ulipristal, Progesterona, Modulador selectivo del receptor de progesterona Resumen: Premenstrual dysphoric disorder (PMDD) is a common mood disorder, characterized by distressing affective, behavioral, and somatic symptoms in the late luteal phase of the menstrual cycle. The authors investigated continuous treatment with a selective progesterone receptor modulator, ulipristal acetate (UPA), as a potential treatment for PMDD. Link: ./index.php?lvl=notice_display&id=26879
in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.3 (Marzo) . - pp. 256-265[artículo] Ulipristal acetate for treatment of premenstrual dysphoric disorder : a proof-of-concept randomized controlled trial [texto impreso] / Erika Comasco, Autor ; Helena Kopp Kallner, Autor ; Marie Bixo, Autor . - 2021 . - pp. 256-265.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.3 (Marzo) . - pp. 256-265
Palabras clave: Trastorno disfórico premenstrual, Neuroendocrinología, Acetato de ulipristal, Progesterona, Modulador selectivo del receptor de progesterona Resumen: Premenstrual dysphoric disorder (PMDD) is a common mood disorder, characterized by distressing affective, behavioral, and somatic symptoms in the late luteal phase of the menstrual cycle. The authors investigated continuous treatment with a selective progesterone receptor modulator, ulipristal acetate (UPA), as a potential treatment for PMDD. Link: ./index.php?lvl=notice_display&id=26879